Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| astrocyte | 16 studies | 45% ± 18% | |
| oligodendrocyte precursor cell | 10 studies | 37% ± 18% | |
| GABAergic neuron | 8 studies | 41% ± 17% | |
| neuron | 8 studies | 39% ± 20% | |
| glutamatergic neuron | 8 studies | 40% ± 21% | |
| interneuron | 6 studies | 41% ± 19% | |
| amacrine cell | 6 studies | 43% ± 18% | |
| retinal ganglion cell | 5 studies | 66% ± 25% | |
| retinal cone cell | 5 studies | 49% ± 27% | |
| retina horizontal cell | 5 studies | 42% ± 17% | |
| pancreatic A cell | 4 studies | 85% ± 7% | |
| type B pancreatic cell | 4 studies | 85% ± 8% | |
| retinal bipolar neuron | 4 studies | 32% ± 13% | |
| neuroendocrine cell | 4 studies | 83% ± 5% | |
| OFF-bipolar cell | 4 studies | 34% ± 16% | |
| enteroendocrine cell | 4 studies | 50% ± 25% | |
| pancreatic D cell | 3 studies | 84% ± 10% | |
| endothelial cell | 3 studies | 30% ± 8% | |
| retinal rod cell | 3 studies | 31% ± 12% | |
| GABAergic amacrine cell | 3 studies | 27% ± 8% | |
| glycinergic amacrine cell | 3 studies | 24% ± 5% | |
| rod bipolar cell | 3 studies | 33% ± 12% | |
| ON-bipolar cell | 3 studies | 41% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 9535.74 | 2633 / 2642 | 99% | 570.38 | 696 / 705 |
| adrenal gland | 14% | 234.68 | 35 / 258 | 67% | 247.48 | 155 / 230 |
| pancreas | 26% | 344.20 | 86 / 328 | 50% | 46.30 | 89 / 178 |
| skin | 0% | 1.42 | 3 / 1809 | 13% | 4.40 | 59 / 472 |
| eye | 0% | 0 | 0 / 0 | 11% | 2.14 | 9 / 80 |
| intestine | 4% | 34.90 | 37 / 966 | 4% | 3.04 | 21 / 527 |
| stomach | 2% | 20.45 | 7 / 359 | 4% | 3.41 | 12 / 286 |
| kidney | 0% | 0 | 0 / 89 | 6% | 10.42 | 54 / 901 |
| lung | 0% | 0 | 0 / 578 | 4% | 2.69 | 47 / 1155 |
| breast | 0% | 0 | 0 / 459 | 3% | 3.23 | 31 / 1118 |
| esophagus | 0% | 0 | 0 / 1445 | 3% | 2.81 | 5 / 183 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.81 | 1 / 45 |
| prostate | 0% | 0 | 0 / 245 | 2% | 0.76 | 11 / 502 |
| ovary | 0% | 0 | 0 / 180 | 2% | 1.16 | 9 / 430 |
| thymus | 1% | 8.43 | 5 / 653 | 1% | 0.25 | 6 / 605 |
| uterus | 0% | 0 | 0 / 170 | 2% | 0.36 | 8 / 459 |
| bladder | 0% | 0 | 0 / 21 | 2% | 1.72 | 8 / 504 |
| liver | 0% | 0 | 0 / 226 | 1% | 0.76 | 6 / 406 |
| blood vessel | 1% | 8.04 | 9 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 0% | 1.08 | 1 / 1204 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0033366 | Biological process | protein localization to secretory granule |
| GO_0005788 | Cellular component | endoplasmic reticulum lumen |
| GO_0030667 | Cellular component | secretory granule membrane |
| GO_0030658 | Cellular component | transport vesicle membrane |
| GO_0005576 | Cellular component | extracellular region |
| GO_0034774 | Cellular component | secretory granule lumen |
| GO_0005515 | Molecular function | protein binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | SCG3 |
| Protein name | Secretogranin-3 (Secretogranin III) (SgIII) Secretogranin-3 (Secretogranin III) |
| Synonyms | UNQ2502/PRO5990 |
| Description | FUNCTION: Member of the granin protein family that regulates the biogenesis of secretory granules . Acts as a sorting receptor for intragranular proteins including chromogranin A/CHGA (By similarity). May also play a role in angiogenesis. Promotes endothelial proliferation, migration and tube formation through MEK/ERK signaling pathway . . |
| Accessions | Q8WXD2 ENST00000558709.1 H0YKC2 ENST00000542355.6 [Q8WXD2-2] ENST00000220478.8 [Q8WXD2-1] |